Stay updated on Exemestane in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Exemestane in NSCLC Clinical Trial page.

Latest updates to the Exemestane in NSCLC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRecruitment status updated to 'No longer looking for participants', indicating the study is not enrolling anymore. New help and navigation sections have been added (How to Read a Study Record, Common Questions, How to Join a Study), the Intervention/Treatment header formatting changed, and the site revision advanced to v3.6.0.SummaryDifference0.4%

- Check19 days agoChange DetectedRevision updated to v3.5.5 on the page, replacing the previous revision v3.5.4. This reflects an internal update to the page's versioning system without altering displayed study content.SummaryDifference0.1%

- Check40 days agoChange DetectedThe sponsor attribution was updated to 'Masonic Cancer Center, University of Minnesota' instead of 'University of Minnesota Masonic Cancer Center', aligning with the institution's preferred naming. A new page revision tag 'Revision: v3.5.4' was added to indicate the latest update.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page’s footer revision/version number was updated from v3.5.2 to v3.5.3, reflecting a change to the ClinicalTrials.gov site build rather than any modification to the study details.SummaryDifference0.1%

- Check69 days agoChange DetectedSite revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check98 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Exemestane in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Exemestane in NSCLC Clinical Trial page.